Cargando…
Nogo-A Neutralization Improves Graft Function in a Rat Model of Parkinson’s Disease
Transplantation of fetal human ventral mesencephalic (VM) dopaminergic neurons into the striatum is a promising strategy to compensate for the characteristic dopamine deficit observed in Parkinson’s disease (PD). This therapeutic approach, however, is currently limited by the high number of fetuses...
Autores principales: | Seiler, Stefanie, Di Santo, Stefano, Widmer, Hans Rudolf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821173/ https://www.ncbi.nlm.nih.gov/pubmed/27092052 http://dx.doi.org/10.3389/fncel.2016.00087 |
Ejemplares similares
-
Antagonization of the Nogo-Receptor 1 Enhances Dopaminergic Fiber Outgrowth of Transplants in a Rat Model of Parkinson’s Disease
por: Seiler, Stefanie, et al.
Publicado: (2017) -
Nogo-A and its functions beyond axonal inhibition: the controversial role of Nogo-A in Parkinson's disease
por: Seiler, Stefanie, et al.
Publicado: (2015) -
Co-Expression of Nogo-A in Dopaminergic Neurons of the Human Substantia Nigra Pars Compacta Is Reduced in Parkinson’s Disease
por: Eyer, Gian-Carlo, et al.
Publicado: (2021) -
Endothelial Progenitor Cells Conditioned Medium Supports Number of GABAergic Neurons and Exerts Neuroprotection in Cultured Striatal Neuronal Progenitor Cells
por: Santo, Stefano Di, et al.
Publicado: (2019) -
Endothelial Progenitor Cell-Derived Factors Exert
Neuroprotection in Cultured Cortical Neuronal Progenitor
Cells
por: Santo, Stefano Di, et al.
Publicado: (2020)